26807-65-8

  • Product Name:Indapamide
  • Molecular Formula:C16H16ClN3O3S
  • Purity:99%
  • Molecular Weight:365.84
Inquiry

Product Details:

CasNo: 26807-65-8

Molecular Formula: C16H16ClN3O3S

Appearance: Crystalline solid

Wholesale! Buy High Grade Indapamide 26807-65-8 Safe Delivery

  • Molecular Formula:C16H16ClN3O3S
  • Molecular Weight:365.84
  • Appearance/Colour:Crystalline solid 
  • Melting Point:160-162 °C 
  • Refractive Index:1.693 
  • Boiling Point:110.4°C (rough estimate) 
  • PKA:pKa (25°) 8.8 ± 0.2 
  • PSA:100.88000 
  • Density:1.51 g/cm3 
  • LogP:4.32040 

Indapamide(Cas 26807-65-8) Usage

Description

Indapamide is a type of medicine classified as a diuretic, commonly known as a "water pill." It works by increasing urine production, helping to eliminate excess fluid from the body. Indapamide is primarily used to treat high blood pressure (hypertension) and salt and fluid retention (edema) associated with congestive heart failure.

Uses

High Blood Pressure (Hypertension):

Indapamide is prescribed alone or in combination with other medications to manage high blood pressure. By reducing blood volume, it helps decrease the workload on the heart and arteries, thus lowering blood pressure.
Congestive Heart Failure:

It is used to treat salt and fluid retention caused by congestive heart failure. By promoting diuresis, indapamide helps reduce fluid buildup in the body, relieving symptoms such as swelling and shortness of breath.

Category toxic

Substances

Toxicity grading

Medium toxicity

Acute toxicity

Oral-rat LD50:> 3000 mg/kg; Oral-mouse LD50:> 3000 mg/kg.

Brand name

Lozol (Sanofi Aventis).

InChI:InChI=1/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)

26807-65-8 Relevant articles

One-pot Synthesis of the Indole Derivative 4-Chloro-3-sulphamoyl-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide (Indapamide)

Ziobro, Barbara,Sienkiewicz, Barbara,Kowalski, Piotr

, p. 95 - 97 (2004)

New methods for the synthesis the indole...

Pharmacokinetics and clinical pharmacology of indapamide

Frank S Caruso Ph.D., Romana R Szabadi Ph.D., Robert A Vukovich Ph.D.

American Heart Journal Volume 106, Issue 1, Part 2, July 1983, Pages 212-220

Disappearance of indapamide from the blood is biphasic, with a terminal half-life of approximately 16 hours. Renal clearance represents less than 10% of the total systemic clearance of the parent drug, showing the dominant role of hepatic clearance. Studies of 14C-labeled indapamide in humans demonstrate that 70% of the radioactivity is excreted in urine and 23% in feces.

26807-65-8 Process route

Dehydroindapamide
63968-75-2

Dehydroindapamide

Indapamide
26807-65-8,77083-52-4

Indapamide

Conditions
Conditions Yield
With sodium tetrahydroborate; hexachloroplatinic acid; hydrogen; In ethanol; at 10 ℃; for 1h;
99.3%
N-amino-2-methylindoline hydrochloride

N-amino-2-methylindoline hydrochloride

C<sub>8</sub>H<sub>5</sub>Cl<sub>2</sub>NO<sub>5</sub>S

C8H5Cl2NO5S

Indapamide
26807-65-8,77083-52-4

Indapamide

Conditions
Conditions Yield
With triethylamine; In dichloromethane; at 15 ℃; for 6h; Temperature; Solvent;
96.89%

26807-65-8 Upstream products

  • 1205-30-7
    1205-30-7

    4-chloro-3-sulphamoylbenzoic acid

  • 31529-46-1
    31529-46-1

    1-amino-2,3-dihydro-2-methylindole

  • 70049-77-3
    70049-77-3

    3-(aminosulfonyl)-4-chlorobenzoyl chloride

  • 7440-44-0
    7440-44-0

    pyrographite

26807-65-8 Downstream products

  • 63968-75-2
    63968-75-2

    Dehydroindapamide

  • 77083-52-4
    77083-52-4

    (R)-indapamide

  • 77083-52-4
    77083-52-4

    (S)-indapamide

  • 1108610-87-2
    1108610-87-2

    C8Cl2N2O2*C16H16ClN3O3S

Relevant Products